Bioventix (LON:BVXP) Stock Price Down 2.6% – Should You Sell?

Bioventix PLC (LON:BVXP)’s stock price fell 2.6% during mid-day trading on Friday . The stock traded as low as GBX 3,450 ($43.54) and last traded at GBX 3,456 ($43.62). 7,664 shares changed hands during mid-day trading, an increase of 31% from the average session volume of 5,833 shares. The stock had previously closed at GBX 3,550 ($44.81).

Bioventix Price Performance

The company has a 50-day simple moving average of GBX 3,712.29 and a 200-day simple moving average of GBX 4,032. The stock has a market cap of £182.70 million, a PE ratio of 2,147.24 and a beta of 0.35.

Bioventix Increases Dividend

The firm also recently disclosed a dividend, which was paid on Thursday, November 21st. Shareholders of record on Thursday, November 7th were given a GBX 87 ($1.10) dividend. This is a boost from Bioventix’s previous dividend of $68.00. The ex-dividend date of this dividend was Thursday, November 7th. This represents a yield of 2.4%. Bioventix’s dividend payout ratio is presently 9,693.25%.

Insider Buying and Selling at Bioventix

In other news, insider Bruce Hiscock bought 24 shares of the stock in a transaction on Friday, November 22nd. The shares were bought at an average price of GBX 3,822 ($48.24) per share, with a total value of £917.28 ($1,157.74). 8.02% of the stock is owned by corporate insiders.

Bioventix Company Profile

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants.